Esperion Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Esperion Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2014 to Q3 2024.
  • Esperion Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 23.7 %, a 59.2% decline year-over-year.
  • Esperion Therapeutics, Inc. annual Return On Equity for 2023 was 53.4 %, a 33.8% decline from 2022.
  • Esperion Therapeutics, Inc. annual Return On Equity for 2022 was 80.7 %, a 15.1% decline from 2021.
  • Esperion Therapeutics, Inc. annual Return On Equity for 2021 was 95 %, a 91.4% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 23.7 -34.4 -59.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 26.2 -41.2 -61.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 22.6 -54.4 -70.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 53.4 -27.2 -33.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 58.1 -36.3 -38.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 67.4 -26.3 -28% Apr 1, 2023 Jun 30, 2023
Q1 2023 77 -7.39 -8.75% Jan 1, 2023 Mar 31, 2023
Q4 2022 80.7 -14.3 -15.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 94.3 -25.2 -21.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 93.6 -103 -52.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 84.4 -146 -63.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 95 -1.01K -91.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 120 +749 Jul 1, 2021 Sep 30, 2021
Q2 2021 196 +468 Apr 1, 2021 Jun 30, 2021
Q1 2021 231 +858 Jan 1, 2021 Mar 31, 2021
Q4 2020 1.11K +1.2K Oct 1, 2020 Dec 31, 2020
Q3 2020 -630 -546 -647% Jul 1, 2020 Sep 30, 2020
Q2 2020 -271 -212 -355% Apr 1, 2020 Jun 30, 2020
Q1 2020 -627 -579 -1190% Jan 1, 2020 Mar 31, 2020
Q4 2019 -98.9 +35.4 +26.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 -84.3 +9.45 +10.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -59.6 +17.1 +22.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 -48.6 +28.8 +37.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -134 -57.5 -74.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -93.8 -19.7 -26.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -76.7 -13.9 -22% Apr 1, 2018 Jun 30, 2018
Q1 2018 -77.5 -34.7 -81% Jan 1, 2018 Mar 31, 2018
Q4 2017 -76.8 -47.7 -164% Oct 1, 2017 Dec 31, 2017
Q3 2017 -74.1 -52.3 -241% Jul 1, 2017 Sep 30, 2017
Q2 2017 -62.8 -43.5 -225% Apr 1, 2017 Jun 30, 2017
Q1 2017 -42.8 -24.7 -136% Jan 1, 2017 Mar 31, 2017
Q4 2016 -29.2 -12.6 -76.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -21.8 -4.19 -23.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 -19.3 +2.15 +10% Apr 1, 2016 Jun 30, 2016
Q1 2016 -18.1 +10.6 +36.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -16.5 +30.4 +64.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 -17.6 +40.9 +70% Jul 1, 2015 Sep 30, 2015
Q2 2015 -21.5 +23.8 +52.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 -28.7 +40.4 +58.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -47 Oct 1, 2014 Dec 31, 2014
Q3 2014 -58.5 Jul 1, 2014 Sep 30, 2014
Q2 2014 -45.2 Apr 1, 2014 Jun 30, 2014
Q1 2014 -69.1 Jan 1, 2014 Mar 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.